139 related articles for article (PubMed ID: 38785168)
1. Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.
Cai A; Meng Y; Zhou H; Cai H; Shao X; Wang Q; Xu Y; Zhou Y; Zhou W; Chen L; Mou S
Adv Sci (Weinh); 2024 May; ():e2404151. PubMed ID: 38785168
[TBL] [Abstract][Full Text] [Related]
2. Primary Membranous Nephropathy.
Couser WG
Clin J Am Soc Nephrol; 2017 Jun; 12(6):983-997. PubMed ID: 28550082
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G; Lorenzen JM; Ma H; de Haan N; Seeger H; Zaghrini C; Brandt S; Kölling M; Wegmann U; Kiss B; Pál G; Gál P; Wüthrich RP; Wuhrer M; Beck LH; Salant DJ; Lambeau G; Kistler AD
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33351779
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.
Teisseyre M; Cremoni M; Boyer-Suavet S; Ruetsch C; Graça D; Esnault VLM; Brglez V; Seitz-Polski B
Front Immunol; 2022; 13():859419. PubMed ID: 35603210
[TBL] [Abstract][Full Text] [Related]
5. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
[TBL] [Abstract][Full Text] [Related]
6. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.
Luo W; Olaru F; Miner JH; Beck LH; van der Vlag J; Thurman JM; Borza DB
Front Immunol; 2018; 9():1433. PubMed ID: 29988342
[TBL] [Abstract][Full Text] [Related]
7. Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.
Chung EYM; Wang YM; Keung K; Hu M; McCarthy H; Wong G; Kairaitis L; Bose B; Harris DCH; Alexander SI
Front Immunol; 2022; 13():1036249. PubMed ID: 36405681
[TBL] [Abstract][Full Text] [Related]
8. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.
Jiang H; Shen Z; Zhuang J; Lu C; Qu Y; Xu C; Yang S; Tian X
Front Immunol; 2023; 14():1335936. PubMed ID: 38288116
[TBL] [Abstract][Full Text] [Related]
9. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
10. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
Gao S; Cui Z; Zhao MH
J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
[TBL] [Abstract][Full Text] [Related]
11. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
Ronco P; Debiec H
Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway.
Jin LW; Pan M; Ye HY; Zheng Y; Chen Y; Huang WW; Xu XY; Zheng SB
Exp Physiol; 2019 Feb; 104(2):220-230. PubMed ID: 30414341
[TBL] [Abstract][Full Text] [Related]
13. [Podocyte depletion in children with hepatitis B virus-associated membranous nephropathy].
Zhang Y; Zhou JH; Wang HT
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):344-8. PubMed ID: 17697619
[TBL] [Abstract][Full Text] [Related]
14. A study of altered calcium sensing system caused primary membranous nephropathy to end-stage renal failure.
Huang L; Zhao YJ; Dong QR; Hu GC
Biomed Pharmacother; 2021 Sep; 141():111777. PubMed ID: 34246186
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy.
Kaga H; Matsumura H; Suzuki T; Dohmae N; Odaka M; Komatsuda A; Takahashi N; Wakui H
Clin Proteomics; 2022 Jul; 19(1):26. PubMed ID: 35836124
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of circulating B cells and kidney cells at the single-cell level in special types of primary membranous nephropathy.
Feng X; Chen Q; Zhong J; Yu S; Wang Y; Jiang Y; Wan J; Li L; Jiang H; Peng L; Wang A; Zhang G; Wang M; Yang H; Li Q
Clin Kidney J; 2023 Dec; 16(12):2639-2651. PubMed ID: 38046035
[TBL] [Abstract][Full Text] [Related]
17. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
18. Cellular response to injury in membranous nephropathy.
Nangaku M; Shankland SJ; Couser WG
J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
[TBL] [Abstract][Full Text] [Related]
19. Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis.
Müller-Deile J; Sopel N; Ohs A; Rose V; Gröner M; Wrede C; Hegermann J; Daniel C; Amann K; Zahner G; Schiffer M
J Am Soc Nephrol; 2021 Nov; 32(11):2777-2794. PubMed ID: 34716242
[TBL] [Abstract][Full Text] [Related]
20. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
Boyce NW; Holdsworth SR
J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
